Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination

Published:2013-10-22 Issue:3 Volume:5 Page:320-326
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Invest

Author:

Shimoda Seiya¹,Iwashita Shinsuke¹,Sekigami Taiji²,Furukawa Noboru¹,Matsuo Yasuto³,Ichimori Shinji⁴,Goto Rieko¹,Maeda Takako¹,Watanabe Eiichiro⁵,Kondo Tatsuya¹,Matsumura Takeshi¹,Motoshima Hiroyuki¹,Nishida Kenro⁶,Araki Eiichi¹

Affiliation:

1. Department of Metabolic Medicine; Faculty of Life Sciences; Kumamoto University; Kumamoto Japan

2. Kumamoto Social Insurance General Hospital; Kumamoto Japan

3. Saiseikai Kumamoto Hospital; Kumamoto Japan

4. Ueki Hospital; Kumamoto Japan

5. Kumamoto Chuo Hospital; Kumamoto Japan

6. Minamata City Hospital and Medical Center; Kumamoto Japan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdi.12151/fullpdf

Reference39 articles.

1. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetes Care,2009

2. Present status of sulfonylurea treatment for type 2 diabetes in Japan: second report of a cross-sectional survey of 15,652 patients;Arai;Endocr J,2010

3. Management of type 2 diabetes: new and future developments in treatment;Tahrani;Lancet,2011

4. Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetes;Harashima;Int J Clin Pract,2012

5. Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes;Nonaka;Diabetes Res Clin Pract,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on Synergistic Effect of Bromocriptine and Sitagliptin in Streptozotocin-induced Diabetic Rats;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2021

2. A safety and tolerability profile comparison between dipeptidyl peptidase-4 inhibitors and sulfonylureas in diabetic patients: A systematic review and meta-analysis;Diabetes Research and Clinical Practice;2019-03

3. The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus;Expert Opinion on Pharmacotherapy;2017-07-17

4. Comparison of the Effects of Mitiglinide and Glibenclamide Administered in Combination with the Dipeptidyl Peptidase-IV Inhibitor Sitagliptin in Rats with Streptozotocin-Nicotinamide-Induced Type 2 Diabetes;Drug Research;2017-05-09

5. A systematic literature review on the efficacy–effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs;Clinical Epidemiology;2017-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3